Q1 2016 13F Holders as of 31 Mar 2016
-
Type / Class
-
Equity / COM NEW
-
Total 13F shares
-
281,791
-
Share change
-
+231,178
-
Total reported value
-
$146,000
-
Price per share
-
$0.52
-
Number of holders
-
7
-
Value change
-
+$119,602
-
Number of buys
-
7
Institutional Holders of IGC Pharma, Inc. - COM NEW (IGC) as of Q1 2016
As of 31 Mar 2016,
IGC Pharma, Inc. - COM NEW (IGC) was held by
7 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
281,791 shares.
The largest 7 holders included
CITADEL ADVISORS LLC, KCG HOLDINGS, INC., SUSQUEHANNA INTERNATIONAL GROUP, LLP, TWO SIGMA SECURITIES, LLC, UBS Group AG, Creative Planning, and Gradient Investments LLC.
This page lists
7
institutional shareholders reporting positions in this security
for the Q1 2016 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.